Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/36871| Title: | Life-long antimicrobial therapy: Where is the evidence?. | Authors: | Lau J.S.Y.;Korman T. ;Woolley I. | Monash Health Department(s): | Infectious Diseases and Clinical Microbiology | Institution: | (Lau, Korman, Woolley) Monash University, Clayton, VIC, Australia (Lau, Korman, Woolley) Monash Infectious Diseases, Monash Health, Clayton, VIC, Australia | Issue Date: | 15-Feb-2019 | Copyright year: | 2018 | Publisher: | Oxford University Press | Place of publication: | United Kingdom | Publication information: | Journal of Antimicrobial Chemotherapy. 73 (10) (pp 2601-2612), 2018. Date of Publication: 2018. | Journal: | Journal of Antimicrobial Chemotherapy | Abstract: | The decision to prescribe long-term or 'life-long' antibiotics in patients requires careful consideration by the treating clinician. While several guidelines exist to help assist in this decision, the long-term consequences are yet to be well studied. In this review, we aim to provide a summary of the available evidence for patient populations where long-term antibiotic therapy is currently recommended in clinical practice. We will also discuss the pitfalls of this approach, including medication adverse effects, economic cost and any possible contribution to the emerging epidemic of microbial resistance.Copyright © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1093/jac/dky174 | PubMed URL: | 29873746 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29873746] | ISSN: | 0305-7453 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/36871 | Type: | Article |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.